InSysBio at AAIC 2022

InSysBio to present posters at AAIC 2022

November 2018

6 1. 06 Nov 2018 17:27 Investigation of amyloid pathology mechanisms and prediction of clinical trial results using QSP model InSysBio presents the video of Tatiana Karelina’s talk in framework of session “From translational PKPD models to quantitative system pharmacology in neurodegeneration drug development” at the 9th American Conference on Pharmacometrics (ACoP9):

26 1. 26 Nov 2018 14:03 InSysBio updates Immune Response Template online InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, today announced a release of updated version of Immune Response Template (IRT) online. The main update in new 2.1.0 version is myeloid-derived suppressor cells (MDSCs). Published human in vitro and in vivo data were analyzed to reconstruct monocytic MDSCs (Mo-MDSCs) and granulocytic MDSCs (Gr-MDSCs) life cycles, derive equations and identify parameters.

events

Conference

July 27, 2022

July 27, 2022

InSysBio announces its participation in AAIC 2022 (Online). Alzheimer’s Association International Conference is held July 31 – August 4, 2022 in San Diego, USA and Online. InSysBio Neurodegeneration Diseases team presents three posters within its frames, namely:

Virtual Platform, Sunday, July 31, 2022: 7:00 AM – 11:55 PM

Poster #65408 "Application of quantitative systems pharmacology model of Alzheimer’s disease for simulation of efficacy of tyrosine kinase inhibitors" by Tatiana Karelina
Poster #63102 "The QSP model of TREM2 influences on inflammatory state of microglia in Alzheimer’s disease" by Stepan Lerner
Poster #65357 "Neurofilament L dynamics description in the model of tauopathy" by Polina Pchelintseva

Our latest posters: InSysBio posters

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Edinburgh, UK (INSYSBIO UK LIMITED), Moscow, Russia (INSYSBIO LLC) and Cyprus (INSYSBIO CY Ltd). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

←	November 2018	→
Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6 1. 06 Nov 2018 17:27 Investigation of amyloid pathology mechanisms and prediction of clinical trial results using QSP model InSysBio presents the video of Tatiana Karelina’s talk in framework of session “From translational PKPD models to quantitative system pharmacology in neurodegeneration drug development” at the 9th American Conference on Pharmacometrics (ACoP9):	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26 1. 26 Nov 2018 14:03 InSysBio updates Immune Response Template online InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, today announced a release of updated version of Immune Response Template (IRT) online. The main update in new 2.1.0 version is myeloid-derived suppressor cells (MDSCs). Published human in vitro and in vivo data were analyzed to reconstruct monocytic MDSCs (Mo-MDSCs) and granulocytic MDSCs (Gr-MDSCs) life cycles, derive equations and identify parameters.	27	28	29	30

Upcoming Events